Ethics, Law and Governance of Biobanking (eBook)
VIII, 277 Seiten
Springer Netherland (Verlag)
978-94-017-9573-9 (ISBN)
Biobank research and genomic information are changing the way we look at health and medicine. Genomics challenges our values and has always been controversial and difficult to regulate. In the future lies the promise of tailored medical treatments and pharmacogenomics but the borders between medical research and clinical practice are becoming blurred. We see sequencing platforms for research that can have diagnostic value for patients. Clinical applications and research have been kept separate, but the blurring lines challenges existing regulations and ethical frameworks. Then how do we regulate it?
This book contains an overview of the existing regulatory landscape for biobank research in the Western world and some critical chapters to show how regulations and ethical frameworks are developed and work. How should international sharing work? How design an ethical informed consent?
An underlying critique: the regulatory systems are becoming increasingly complex and opaque. The international community is building systems that should respond to that. According to the authors in fact, it is time to turn the ship around. Biobank researchers have a moral responsibility to look at and assess their work in relation to the bigger picture: the shared norms and values of current society. Research ethics shouldn't only be a matter of bioethicists writing guidelines that professionals have to follow. Ethics should be practiced through discourse and regulatory frameworks need to be part of that public discourse. Ethics review should be then not merely application of bureaucracy and a burden for researchers but an arena where researchers discuss their projects, receive advice and practice their ethics skills.
Author's affiliation is:
Deborah Mascalzoni
Centre for Biomedicine
European Academy Bolzano
Viale Druso 1, 39100 Bolzano
This book contains an overview of the existing regulatory landscape for biobank research in the Western world and some critical chapters to show how regulations and ethical frameworks are developed and work. How should international sharing work? How do we design an ethically informed consent? Biobank research and genomic information are changing the way we look at health and medicine. Genomics challenge our values and have always been controversial and difficult to regulate. In the future lies the promise of tailored medical treatments and pharmacogenomics but the borders between medical research and clinical practice are becoming blurred. We see sequencing platforms for research that can have diagnostic value for patients. Clinical applications and research have been kept separate, but the blurring lines challenge existing regulations and ethical frameworks. Then how do we regulate it?An underlying critique: the regulatory systems are becoming increasingly complex and opaque. The international community is building systems that should respond to that. The authors argue that it is time to turn the ship around. Biobank researchers have a moral responsibility to look at and assess their work in relation to the bigger picture: the shared norms and values of current society. Research ethics shouldn't only be a matter of bioethicists writing guidelines that professionals have to follow. Ethics should be practiced through discourse and regulatory frameworks need to be part of that public discourse. Ethics review should therefore not merely be an application of bureaucracy and a burden for researchers but an arena where researchers discuss their projects, receive advice and practice their ethics skills.
Author's affiliation is:Deborah MascalzoniCentre for BiomedicineEuropean Academy BolzanoViale Druso 1, 39100 Bolzano
Introduction; Deborah Mascalzoni.- Biobanks: a definition; Barbara Parodi.- A participatory space beyond the "autonomy versus property" dichotomy; Mariachiara Tallacchini.- Intellectual Property and Biobanks; Naomi Hawkins.- Consent, Privacy and Property in the Italian Biobanks Regulation: A Hybrid Model within EU?; Matteo Macilotti, Simone Penasa, Marta Tomasi.- Data Protection Principles and Research in the Biobanks Age; Roberto Lattanzi.- The New General Data Protection Regulation – where are we are and where might we be heading?; Jane Reichel and Anna-Sara Lind.- The Tension between Data Sharing and the Protection of Privacy in Genomics Research; Jane Kaye.- Incidental findings: the time is not yet ripe for a policy for biobanks; Jennifer Viberg, Mats G. Hansson, Sophie Langenskiöld, Pär Segerdahl.- Biobanking across borders: the challenges of harmonization; Ruth Chadwick, Heather Strange.- Governing Biobanks Through A European Infrastructure; Emmanuelle Rial-Sebbag, Anne Cambon-Thomsen.- EU governance for research and ethics in biobanks; Jane Reichel.- A Bold Experiment: Iceland’s Genomic Venture ; David Winickoff.- The Estonian Genome Center, University of Tartu; Aime Keis.- The management of the ethical aspects of a local mental diseases biobank for research purposes. An Italian experience; Corinna Porteri.- Biobank governance in Spain: From the autonomy of research ethics committees to the autonomy of lay people; Antonio Casado da Rocha.- Public deliberation and the role of stakeholders as a new frontier in the governance of science: the British Columbia Biobank Deliberation and the DePGx Project; Claudio Corradetti, Gillian Bartlett.- Making researchers moral; Linus Johnsson, Stefan Eriksson, Gert Helgesson, Mats G. Hansson.
| Erscheint lt. Verlag | 22.1.2015 |
|---|---|
| Reihe/Serie | The International Library of Ethics, Law and Technology | The International Library of Ethics, Law and Technology |
| Zusatzinfo | VIII, 277 p. |
| Verlagsort | Dordrecht |
| Sprache | englisch |
| Themenwelt | Geisteswissenschaften ► Philosophie ► Allgemeines / Lexika |
| Geisteswissenschaften ► Philosophie ► Ethik | |
| Medizin / Pharmazie ► Allgemeines / Lexika | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Medizinethik | |
| Studium ► Querschnittsbereiche ► Geschichte / Ethik der Medizin | |
| Naturwissenschaften ► Biologie | |
| Recht / Steuern ► EU / Internationales Recht | |
| Recht / Steuern ► Privatrecht / Bürgerliches Recht ► Medizinrecht | |
| Schlagworte | BBMRI • Biobanks • Bioethics • biorepositories • biorepository • cell factories • cell factory • genetic database • Governance of Biobanking • health database • P3G • post-genomic • tissue bank |
| ISBN-10 | 94-017-9573-8 / 9401795738 |
| ISBN-13 | 978-94-017-9573-9 / 9789401795739 |
| Haben Sie eine Frage zum Produkt? |
PDF (Ohne DRM)Digital Rights Management: ohne DRM
Dieses eBook enthält kein DRM oder Kopierschutz. Eine Weitergabe an Dritte ist jedoch rechtlich nicht zulässig, weil Sie beim Kauf nur die Rechte an der persönlichen Nutzung erwerben.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
